Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor
Clinical trial NCT06289166 · COMPLETED
Trial details
- NCT number
- NCT06289166
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-18
- Primary completion
- 2024-10-17
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.